BIOMAT Database Logo BIOMAT Database Logo

Clear Cell Hidradenoma-Basal Cell Carcinoma Collision. 2021

Enric Piqué-Duran, and MªCristina Duran-Hernández, and Juan A Pérez-Cejudo, and Odalys García-Vázquez
Departments of Dermatology, and.

A 91-year-old man presented with a tumor on the left temporal area, clinically suspicious of basal cell carcinoma. The histopathologic study showed a central solid-cystic tumor composed by 3 different types of cells (clear or finely granular cells, polygonal cells, and squamoid cells). It had a sclerotic stroma. At the periphery, another tumor composed by smaller interconnected nests was evident. Some nests were separated from the stroma by clefts. The stroma of this second tumor was highly cellular. There was a sharp delimitation between both tumors, with no transitional area. Immunochemistry demonstrated they are different tumor. A diagnosis of clear cell hidradenoma-basal cell carcinoma collision was performed. To the best of our knowledge, this is the first description of this challenging association.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D002280 Carcinoma, Basal Cell A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471) Carcinoma, Basal Cell, Pigmented,Epithelioma, Basal Cell,Rodent Ulcer,Ulcer, Rodent,Basal Cell Carcinoma,Basal Cell Carcinomas,Basal Cell Epithelioma,Basal Cell Epitheliomas,Carcinomas, Basal Cell,Epitheliomas, Basal Cell,Rodent Ulcers,Ulcers, Rodent
D006258 Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) Cancer of Head and Neck,Head Cancer,Head Neoplasm,Head and Neck Cancer,Head and Neck Neoplasm,Neck Cancer,Neck Neoplasm,Neck Neoplasms,Neoplasms, Upper Aerodigestive Tract,UADT Neoplasm,Upper Aerodigestive Tract Neoplasm,Upper Aerodigestive Tract Neoplasms,Cancer of Head,Cancer of Neck,Cancer of the Head,Cancer of the Head and Neck,Cancer of the Neck,Head Neoplasms,Head, Neck Neoplasms,Neoplasms, Head,Neoplasms, Head and Neck,Neoplasms, Neck,UADT Neoplasms,Cancer, Head,Cancer, Neck,Cancers, Head,Cancers, Neck,Head Cancers,Neck Cancers,Neoplasm, Head,Neoplasm, Neck,Neoplasm, UADT,Neoplasms, UADT
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies
D013544 Sweat Gland Neoplasms New abnormal growth of tissue in the SWEAT GLANDS. Neoplasms, Sweat Gland,Neoplasm, Sweat Gland,Sweat Gland Neoplasm
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D018193 Neoplasms, Complex and Mixed Neoplasms composed of more than one type of neoplastic tissue. Complex and Mixed Neoplasms

Related Publications

Enric Piqué-Duran, and MªCristina Duran-Hernández, and Juan A Pérez-Cejudo, and Odalys García-Vázquez
Superficial hidradenoma and basal-cell carcinoma.
October 1966, The Journal of pathology and bacteriology,
Enric Piqué-Duran, and MªCristina Duran-Hernández, and Juan A Pérez-Cejudo, and Odalys García-Vázquez
Clear cell hidradenoma.
May 2006, Journal of the American Academy of Dermatology,
Enric Piqué-Duran, and MªCristina Duran-Hernández, and Juan A Pérez-Cejudo, and Odalys García-Vázquez
Clear cell hidradenoma.
January 2013, Advanced biomedical research,
Enric Piqué-Duran, and MªCristina Duran-Hernández, and Juan A Pérez-Cejudo, and Odalys García-Vázquez
[Clear-cell hidradenoma].
January 1972, Arkhiv patologii,
Enric Piqué-Duran, and MªCristina Duran-Hernández, and Juan A Pérez-Cejudo, and Odalys García-Vázquez
[Clear cell hidradenoma].
January 1969, Przeglad dermatologiczny,
Enric Piqué-Duran, and MªCristina Duran-Hernández, and Juan A Pérez-Cejudo, and Odalys García-Vázquez
Clear-cell hidradenoma.
October 1958, The Journal of pathology and bacteriology,
Enric Piqué-Duran, and MªCristina Duran-Hernández, and Juan A Pérez-Cejudo, and Odalys García-Vázquez
Malignant clear-cell hidradenoma.
August 1987, Plastic and reconstructive surgery,
Enric Piqué-Duran, and MªCristina Duran-Hernández, and Juan A Pérez-Cejudo, and Odalys García-Vázquez
Malignant clear cell hidradenoma.
January 1993, Dermatology (Basel, Switzerland),
Enric Piqué-Duran, and MªCristina Duran-Hernández, and Juan A Pérez-Cejudo, and Odalys García-Vázquez
Clear cell Basal cell carcinoma.
April 2011, Pathology research international,
Enric Piqué-Duran, and MªCristina Duran-Hernández, and Juan A Pérez-Cejudo, and Odalys García-Vázquez
Clear cell basal cell carcinoma.
November 1990, Histopathology,
Copied contents to your clipboard!